The pharmaceutical industry is continuously evolving, with substantial demand for high-efficacy Active Pharmaceutical Ingredients (APIs). Dulaglutide, a GLP-1 receptor agonist, is a key example of this trend. To https://mirrorbookmarks.com/story20390099/leading-us-based-dulaglutide-api-manufacturing-services